Results 191 to 200 of about 18,095,855 (237)
Some of the next articles are maybe not open access.

Carboxylate-derived calixarenes with high selectivity for actinium-225

Chemical Communications, 1998
The binding properties of two ligands, 5,11,17,23-tetra-tert-butyl-25,26,27,28-tetrakis(carboxymethoxy)calix[4]arene 1 and 5,11,17,23,29,35-hexa-tert-butyl-37,38,39,40,41,42- hexakiscarboxymethoxy)calix[6]arene 2, which show high selectivity for 225Ac3+ (an α-emitter with t1/2 = 10 days) over Na+, K+, Mg2+, Ca2+ and Zn2+ are described.
Xiaoyuan Chen   +4 more
openaire   +1 more source

Actinium-225-DOTATATE

Reactions Weekly, 2023
openaire   +1 more source

Actinium-225-dotatoc

Reactions Weekly, 2023
openaire   +1 more source

Accelerating actinium-225 purification by high-pressure ion chromatography

Journal of Chromatography A
Actinium-225 (t1/2 = 9.92 days) is an important radioisotope for targeted alpha therapy applications. The limited supply obtained through the decay of thorium-229 has motivated accelerator-based production routes, including irradiation of thorium targets.
Kevin Gaddis   +7 more
openaire   +2 more sources

Clinical Studies with Bismuth-213 and Actinium-225 for Hematologic Malignancies

Current Radiopharmaceuticals, 2018
Due to the shorter range and higher linear energy transfer of α-particles compared to β-particles, targeted α-particle therapy may produce more efficient tumor killing while sparing neighboring healthy cells. We will review the clinical studies using α-particle therapy for Acute Myeloid Leukemia (AML).A series of clinical trials were conducted to ...
openaire   +2 more sources

The Coordination Properties and Ionic Radius of Actinium: A 120-Year-Old Enigma

Coordination Chemistry Reviews, 2021
Annie B. Kersting   +2 more
exaly  

Production and Quality Control of Actinium-225 Radiopharmaceuticals

This publication includes existing experiences, lessons learned, challenges and future developments in the production of Ac-225 radiopharmaceuticals for Targeted Alpha Therapy (TAT). This publication will be utilized by all involved professionals in the Targeted Alpha Therapy field, specifying ideal production, formulation, quality control and ...
openaire   +1 more source

Firms launch an actinium-225 venture

C&EN Global Enterprise, 2023
openaire   +1 more source

SpectronRX plans actinium-225 in Indiana

Chemical & Engineering News, 2022
openaire   +1 more source

Home - About - Disclaimer - Privacy